Is Crenessity being discontinued?

As of Oct 24, 2026, FDA lists discontinuation notices for Crinecerfont Capsule, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).

When will the Crenessity shortage end?

FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.

Does FDA list alternatives to Crenessity?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Crenessity (Crinecerfont Capsule) being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Crenessity: being discontinued (FDA, Oct 24)

Capsules

A generic capsule, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

DRUG

Crenessity

FDA LISTING

Crinecerfont Capsule

FORM

capsules

STATUS

Discontinuation

FIRST POSTED

Apr 28, 2026

LAST FDA UPDATE

Apr 28, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Crinecerfont Capsule. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

Neurocrine Biosciences, Inc. told FDA it will discontinue Crenessity (posted Apr 28, 2026).
“Neurocrine is discontinuing only the 25 mg soft gel capsule dose strength (NDC 70370-5025-01). The 50mg and 100mg soft gel capsule dose strength (NDC 70370-5050-1 and 70370-5100-1), and 50 mg/mL oral solution will continue to be marketed (NDC 70370-5250-1).”
FDA listing: Crinecerfont Capsule

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Crenessity being discontinued?: As of Oct 24, 2026, FDA lists discontinuation notices for Crinecerfont Capsule, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Crenessity shortage end?: FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Crenessity?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.